不同传统功法对慢性阻塞性肺疾病稳定期患者肺功能影响的网状Meta分析

目的 系统评估不同传统功法对慢性阻塞性肺疾病（COPD）稳定期患者肺功能的疗效差异，为临床提供最优功法干预方案。方法 系统检索由建库到2021年4月在Cochrane Library、Scopus、Pro Quest、Pub Med、Web of Science、中国知识资源总库（CNKI）、中国学术期刊数据库（万方数据）、中文科技期刊数据库（维普网）、中国生物医学文献数据库（CBM）收录的多种传统功法治疗COPD稳定期肺功能的随机对照试验（RCT）。纳入文献的风险偏倚根据Cochrane5.1.0手册设立的标准进行评估，并采用Stata14.0和GeMTC0.14.3软件对提取的数据进行网状Meta分析。结果 共纳入RCT 37项，涉及患者2 499例。网状Meta分析结果显示，与常规治疗组比较，各功法组在提高第1秒用力呼气容积/用力肺活量（FEV1/FVC）方面更优（P<0.05）；各功法组FEV1/FVC比较差异无统计学意义（P>0.05）。等级概率排序结果显示，六字诀组改善FEV1/FVC效果最佳。结论 基于当前证据，在改善COPD稳定期患者肺功能方面，六字诀可能为...

Network Meta-Analysis on Different Traditional Health-preserving Methods on Lung Function of Patients with Chronic Obstructive Pulmonary Disease in Stable Stage

Objective To systematically evaluate the differences in the effects of different traditional health-preserving methods on the lung function of patients with chronic obstructive pulmonary disease(COPD)in stable stage,and to provide the best intervention method for clinical practice.Methods The study searched randomized controlled trials(RCTs)published from the establishment to April 2021 about various traditional methods for the treatment of lung function in stable COPD in Chinese and English databases such as Cochrane Library,Scopus,ProQuest,PubMed,Web of Science and CNKI,Wanfang Data,VIP and CBM.The risk bias of the included literature was assessed according to the standards established by the Cochrane 5.1.0 manual,and the extracted data were analyzed by network meta-analysis using Stata14.0 and GeMTC0.14.3 software.Results Totally 37 RCTs were finally included,with a total of 2499 patients.The results of the network Meta-analysis showed that in the index of forced expiratory volume in the first second/forced vital capacity(FEV1/FVC),compared with the conventional treatment group,each exercise group was better in improving FEV1/FVC(P<0.05);there was no statistically significant difference in FEV1/FVC among exercise groups(P>0.05).The rank probability ranking results showed that the Liuzijue group had the best effect in improving FEV1/FVC.Conclusion Based on current evidence,Liuzijue may be the best intervention to improve lung function in patients with stable COPD.